These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Symptom control and palliative care: management of breathlessness. Oxberry SG; Lawrie I Br J Hosp Med (Lond); 2009 Apr; 70(4):212-6. PubMed ID: 19357599 [TBL] [Abstract][Full Text] [Related]
4. [Dyspnea in cancer: causes and symptomatic treatment]. Sleijfer DT; van der Werf TS; de Mulder PH Ned Tijdschr Geneeskd; 1999 Nov; 143(48):2421-4. PubMed ID: 10608976 [TBL] [Abstract][Full Text] [Related]
5. Interventions for alleviating cancer-related dyspnea: a systematic review. Ben-Aharon I; Gafter-Gvili A; Paul M; Leibovici L; Stemmer SM J Clin Oncol; 2008 May; 26(14):2396-404. PubMed ID: 18467732 [TBL] [Abstract][Full Text] [Related]
6. [Dyspnea in palliative medicine]. Pohl G Wien Med Wochenschr; 2009 Dec; 159(23-24):565. PubMed ID: 20151343 [No Abstract] [Full Text] [Related]
7. Pharmacologic management of nonpain symptoms in surgical patients. Bruera E; Beattie-Palmer LN Surg Oncol Clin N Am; 2001 Jan; 10(1):89-107. PubMed ID: 11406453 [TBL] [Abstract][Full Text] [Related]
8. Interventions for alleviating cancer-related dyspnea: a systematic review and meta-analysis. Ben-Aharon I; Gafter-Gvili A; Leibovici L; Stemmer SM Acta Oncol; 2012 Nov; 51(8):996-1008. PubMed ID: 22934558 [TBL] [Abstract][Full Text] [Related]
11. Morphine for dyspnea control in terminal cancer patients: is it appropriate in Taiwan? Hu WY; Chiu TY; Cheng SY; Chen CY J Pain Symptom Manage; 2004 Oct; 28(4):356-63. PubMed ID: 15471653 [TBL] [Abstract][Full Text] [Related]
13. Pharmacologic management of cancer-related pain, dyspnea, and nausea. Cheung WY; Zimmermann C Semin Oncol; 2011 Jun; 38(3):450-9. PubMed ID: 21600377 [TBL] [Abstract][Full Text] [Related]
14. The therapeutics of dyspnoea. Davis CL Cancer Surv; 1994; 21():85-98. PubMed ID: 8565001 [TBL] [Abstract][Full Text] [Related]
15. [Palliation of dyspnea in malignant disease]. de la Fuente Fonnest I; Hjortshøj KM; Strömgren LA Ugeskr Laeger; 1999 Jan; 161(3):244-8. PubMed ID: 10025221 [TBL] [Abstract][Full Text] [Related]
16. Oral transmucosal fentanyl citrate for dyspnea in terminally ill patients: an observational case series. Gauna AA; Kang SK; Triano ML; Swatko ER; Vanston VJ J Palliat Med; 2008 May; 11(4):643-8. PubMed ID: 18454622 [TBL] [Abstract][Full Text] [Related]
17. [Symptomatic treatment of dyspnoea in patients receiving palliative care: nasal delivery of oxygen compared with opioid administration]. Clemens KE; Klaschik E Dtsch Med Wochenschr; 2007 Sep; 132(38):1939-43. PubMed ID: 17853348 [TBL] [Abstract][Full Text] [Related]
19. The Current Practice of Opioid for Cancer Dyspnea: The Result From the Nationwide Survey of Japanese Palliative Care Physicians. Yamaguchi T; Matsunuma R; Suzuki K; Matsuda Y; Mori M; Watanabe H J Pain Symptom Manage; 2019 Oct; 58(4):672-677.e2. PubMed ID: 31201876 [TBL] [Abstract][Full Text] [Related]
20. Noninvasive ventilation at the end of life. Benditt JO Respir Care; 2000 Nov; 45(11):1376-81; discussion 1381-4. PubMed ID: 11063525 [No Abstract] [Full Text] [Related] [Next] [New Search]